Artificial intelligence (AI) is increasingly used in oncology to support tasks such as clinical-trial matching, evidence ...

What 195 Clinical Trials Reveal About the State of Artificial Intelligence in Oncology and Hematology in 2026.

Daiichi Sankyo and Merck & Co/MSD have withdrawn their U.S. application seeking accelerated approval of ifinatamab deruxtecan ...

Rare cancers can expose a difficult gap between advances in precision oncology and the systems that determine access to ...

Breast cancer prevention remains an important opportunity to move care earlier in the disease continuum, particularly by ...

Biotech leadership cannot stay static as a company moves from the benchtop to the clinic, writes, CEO of CERo Therapeutics.

For patients with early-stage lung cancer who cannot undergo surgery, precision radiation therapy is the main curative-intent ...

Steven Quay M.D., Ph.D. has served as President and Chief Executive Officer since founding Atossa Therapeutics in 2009. A ...

For many patients with cancer, access to a clinical trial still depends on where the trial is located, not just whether a ...

A Radioactive Bandage Offers a New Brachytherapy Approach for Selected Non-Melanoma Skin Cancers. CivaDerm™ delivers ...

Carboplatin and cisplatin are platinum-based chemotherapies that have been fundamental components of cancer treatment for decades. They are used across multiple malignancies, including lung, ovarian, ...

Sylvester researchers will compare circulating tumor DNA (ctDNA) against standard tissue testing in roughly 490 plasma samples drawn from patients enrolled in PanCAN’s Precision Promise trial network, ...